Search All UT System Experts

A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia

John Schindler, Srikanth Gajavelli, Farhad Ravandi, Yumin Shen, Samir Parekh, Ira Braunchweig, Stefan Barta, Victor Ghetie, Ellen Vitetta, Amit Verma

Research output: Contribution to journal › Article › peer-review

80 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia'. Together they form a unique fingerprint.

Medicine & Life Sciences